AstraZeneca says Imfinzi combo shows promise in late-stage lung cancer trial
- ByReuters-
(Reuters) - AstraZeneca (NASDAQ:AZN) said on Thursday a combination of its cancer drug, Imfinzi, and chemotherapy showed promise in a late-stage trial in patients with an...